Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
J Clin Oncol 2020 Dec 04
Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.
Related Questions
Should 3 years of adjuvant osimertinib be the standard of care for resected Stage IB-IIIA EGFRm NSCLC?
7245
×
To continue please login or register
Register
or
Sign in